FDA advisory panel turns down PneumRx’s Elevair lung implant

FDA advisory panel turns down PneumRx’s Elevair lung implant

Source: 
Fierce Biotech
snippet: 

An FDA advisory committee panel voted against recommending premarket approval for PneumRx’s Elevair lung implant for patients with severe emphysema.